Clinical Study
Circulating Tissue Inhibitor of Matrix Metalloproteinase-4 (TIMP-4) in Systemic Sclerosis Patients with Elevated Pulmonary Arterial Pressure
Table 2
Pulmonary function tests (mean SD
of % predicted, number of patients with less
than 80% of predicted) in patients with systemic sclerosis (SSc).
| ||||||||||||||||||||||||||||||||||||
FEV1: forced expiratory volume
at 1 second;FVC: forced vital capacity;TLC: total lung capacity;DLCO: diffusing lung capacity
for carbon monoxide. |